Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors
作者:Bo-Liang Deng、Yujie Zhao、Tracy L. Hartman、Karen Watson、Robert W. Buckheit Jr.、Christophe Pannecouque、Erik De Clercq、Mark Cushman
DOI:10.1016/j.ejmech.2008.09.013
日期:2009.3
stable bioisosteres, compounds bearing benzo[d]isoxazole and oxazolidine-2-one rings were designed and evaluated as a new series of potent HIV-1 non-nucleoside reverse transcriptase inhibitors with anti-HIV activity. All of the resulting ADAMs were found to inhibit HIV-1 RT with poly(rC)·oligo(dG) as the template primer. The most promising compound in this series was ADAM 3, with EC50 values of 40 nM (vs
为了继续用稳定的生物等排体取代链烯基二芳基碳酸铅的代谢不稳定的甲基酯(ADAM),设计了带有苯并[ d ]异恶唑和恶唑烷-2-酮环的化合物,并将其评估为一系列新的有效HIV-1非-具有抗HIV活性的核苷逆转录酶抑制剂。发现所有所得的ADAM均以poly(rC)·oligo(dG)为模板引物抑制HIV-1 RT。该系列中最有前途的化合物是ADAM 3,其EC 50值为40 nM(vs HIV-1 RF)和20 nM(vs HIV-1 IIIB)。化合物3还抑制HIV-1逆转录酶,IC 50为0.91μM。ADAM 4在CEM-SS细胞中具有0.6μM的抗病毒EC 50和51.4分钟的血浆半衰期。